The outlook of companies tied to blockbuster drugs like Viagra presents a complex investment landscape . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the patent expiration in key territories has introduced significant uncertainty . Investors are now facing the impact of lower-cost